Viropharma, Inc. (VPHM) Misses Q1 EPS by 5c; Guides FY12 Revs Below Views
Tweet
Share
E-mailGet Alerts VPHM Hot Sheet
Price: $49.96 --0%
Financial Fact:
Other operating expenses: 3.61M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Other operating expenses: 3.61M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Viropharma, Inc. (NASDAQ: VPHM) reported Q1 EPS of $0.37, $0.05 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $135.8 million versus the consensus estimate of $149.16 million.
Sees FY2012 revenue of $450-$500 million, versus the consensus of $502.43 million.
For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.
Sees FY2012 revenue of $450-$500 million, versus the consensus of $502.43 million.
For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- Global Water Resources (GWRS) Tops Q2 EPS by 1c
- Salem Media Group (SALM) Reports Q2 Loss of $0.11
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
